{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-124568","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.426761+00:00","generated_at":"2026-05-29T11:13:11.743875+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ReShape Lifesciences receives Nasdaq delisting notice for stockholders' equity below $2.5M","bullets":["As of Sept 30, 2024, stockholders' equity was $1,487,000, below Nasdaq's $2.5M minimum.","Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180-day extension.","Intends to monitor performance and consider available options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-124568","json":"https://secwatch.observer/filing/0001104659-24-124568.json","markdown":"https://secwatch.observer/filing/0001104659-24-124568.md","text":"https://secwatch.observer/filing/0001104659-24-124568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/0001104659-24-124568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/tm2419158d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T11:13:11.743875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}